loadpatents
name:-0.019850969314575
name:-0.0086629390716553
name:-0.00036191940307617
Purohit; Prashant Patent Filings

Purohit; Prashant

Patent Applications and Registrations

Patent applications and USPTO patent grants for Purohit; Prashant.The latest application filed is for "process for the preparation of regorafenib and its crystalline forms".

Company Profile
0.10.20
  • Purohit; Prashant - Raichur IN
  • Purohit; Prashant - Karnataka N/A IN
  • Purohit; Prashant - Vizianagaram IN
  • Purohit; Prashant - Rajendra Gunj Raichur IN
  • Purohit; Prashant - Deosugur IN
  • Purohit; Prashant - Raiehur IN
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Process for the preparation of regorafenib and its crystalline forms
Grant 9,790,185 - Rampalli , et al. October 17, 2
2017-10-17
Process For The Preparation Of Regorafenib And Its Crystalline Forms
App 20170204062 - RAMPALLI; SRIRAM ;   et al.
2017-07-20
Crystalline Lenalidomide Process
App 20170107193 - RAMPALLI; SRIRAM ;   et al.
2017-04-20
Crystalline erlotinib hydrochloride process
Grant 9,593,083 - Shrawat , et al. March 14, 2
2017-03-14
Process For Preparing Amorphous Cabazitaxel
App 20160340327 - RAMPALLI; SRIRAM ;   et al.
2016-11-24
Crystalline Dasatinib Process
App 20160264565 - RAMPALLI; SRIRAM ;   et al.
2016-09-15
Process for preparing amorphous cabazitaxel
Grant 9,403,785 - Shrawat , et al. August 2, 2
2016-08-02
Fingolimod polymorphs and their processes
Grant 9,266,816 - Shrawat , et al. February 23, 2
2016-02-23
Process For Preparing Amorphous Cabazitaxel
App 20150315164 - RAMPALLI; SRIRAM ;   et al.
2015-11-05
Crystalline Erlotinib Hydrochloride Process
App 20150299141 - Shrawat; Vimal Kumar ;   et al.
2015-10-22
Process for preparing dasatinib monohydrate
Grant 9,145,406 - Purohit , et al. September 29, 2
2015-09-29
Highly pure bendamustine hydrochloride monohydrate
App 20150175554 - Shrawat; Vimal Kumar ;   et al.
2015-06-25
Process For Preparing Crystalline Sorafenib Tosylate
App 20150111929 - Purohit; Prashant ;   et al.
2015-04-23
Process For Preparing Dasatinib Monohydrate
App 20150057446 - Purohit; Prashant ;   et al.
2015-02-26
Process for preparing bicalutamide
Grant 8,895,772 - Shrawat , et al. November 25, 2
2014-11-25
Process For Preparing Amorphous Cabazitaxel
App 20140336246 - Shrawat; Vimal Kumar ;   et al.
2014-11-13
Process for preparing docetaxel and its hydrate
Grant 8,829,210 - Shrawat , et al. September 9, 2
2014-09-09
Process For Preparing Docetaxel And Its Hydrate
App 20140039209 - Shrawat; Vimal Kumar ;   et al.
2014-02-06
Fingolimod Polymorphs And Their Processes
App 20130281739 - Shrawat; Vimal Kumar ;   et al.
2013-10-24
Process For Preparing Bicalutamide
App 20130274501 - Shrawat; Vimal Kumar ;   et al.
2013-10-17
Process For Preparing Bendamus Tine Hydrochloride Monohydrate
App 20130217888 - Shrawat; Vimal Kumar ;   et al.
2013-08-22
Process for High Purity Anastrozole
App 20090286989 - Vishnukant; B. ;   et al.
2009-11-19
Process for the Preparation of Irinotecan Hydrochloride Trihydrate
App 20080182990 - Vishnukant; B. ;   et al.
2008-07-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed